Abstract | PURPOSE: METHODS: Sprague-Dawley male rats were divided into 3 groups as follows: (1) nondiabetic control group (non-DM control); (2) diabetic control group (DM control); and (3) diabetic rats receiving H(2) saline therapy (DM H(2) saline). Rats in DM H(2) saline group were intraperitoneally injected with H(2) saturated saline (5 mL/kg) every day for 4 weeks. Retinal vascular permeability was assessed by measuring Evans blue leakage into the retina. Retinal apoptosis was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and measuring caspase-3 activity. Retinal thickness was observed by hematoxylin and eosin staining. RESULTS: Our results showed that H(2) saline treatment could depress the caspase activity, reduce the retinal apoptosis, and vascular permeability. The H(2) saline could also prominently attenuate the retinal parenchyma thickening that resulted from diabetic retinopathy. CONCLUSIONS: Our preliminary studies indicated that H(2) saline may have potentials in the clinical treatment of diabetic retinopathy.
|
Authors | Xiang Xiao, Jiping Cai, Jiajun Xu, Ruobing Wang, Jianmei Cai, Yun Liu, Weigang Xu, Xuejun Sun, Runping Li |
Journal | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
(J Ocul Pharmacol Ther)
Vol. 28
Issue 1
Pg. 76-82
(Feb 2012)
ISSN: 1557-7732 [Electronic] United States |
PMID | 21790325
(Publication Type: Journal Article)
|
Chemical References |
- Sodium Chloride
- Streptozocin
- Hydrogen
- Caspase 3
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Capillary Permeability
(drug effects)
- Caspase 3
(metabolism)
- Diabetes Mellitus, Experimental
(complications)
- Diabetic Retinopathy
(prevention & control)
- Hydrogen
(chemistry, pharmacology)
- In Situ Nick-End Labeling
- Injections, Intraperitoneal
- Male
- Rats
- Rats, Sprague-Dawley
- Retina
(drug effects, pathology)
- Sodium Chloride
(chemistry, pharmacology)
- Streptozocin
|